CLINICAL_TRIALS
trial_result
· 2010-02-11
Clinical Trial Update: Effects of Adalimumab on Mucosal Healing in Subjects With Crohn's Disease Involving the Colon [Phase 3]
Summary
A Phase 3 clinical trial evaluated adalimumab for mucosal healing in Crohn's disease involving the colon; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Abbott | Conditions: Crohn's Disease | Phase 3 | Status: COMPLETED | Results posted: 2010-02-11